DBV Technologies (DBVT) Return on Capital Employed Growth (1y) (2022 - 2026)
DBV Technologies (DBVT) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 2,400.00 |
| 10 | DBV Technologies | 5.97 Bn | 5.80 Bn | - | 16,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16,288.00 |
| Mar 31, 2026 | 56,178.00 |
| Dec 31, 2025 | 11,292.00 |
| Sep 30, 2025 | -1,849.00 |
| Jun 30, 2025 | -16,604.00 |
| Mar 31, 2025 | -58,592.00 |
| Dec 31, 2024 | -19,050.00 |
| Sep 30, 2024 | -8,439.00 |
| Jun 30, 2024 | -3,688.00 |
| Mar 31, 2024 | -1,194.00 |
| Dec 31, 2023 | -691.00 |
| Sep 30, 2023 | -2,927.00 |
| Jun 30, 2023 | -740.00 |
| Mar 31, 2023 | 3,199.00 |
| Dec 31, 2022 | 3,302.00 |
| Sep 30, 2022 | 5,219.00 |
| Jun 30, 2022 | 2,994.00 |
| Mar 31, 2022 | -1,001.00 |